Longitudinal assessment of T cell inhibitory receptors in liver transplant recipients and their association with posttransplant infections. Academic Article uri icon

Overview

abstract

  • Current immunosuppression regimens in organ transplantation primarily inhibit T cells. However, T cells are also critical in protective immunity, especially in immune-compromised patients. In this study, we examined the association of T cell dysfunction, as marked by expression of T cell exhaustion molecules, and posttransplant infections in a cohort of liver transplant patients. We focused on Programmed Death 1 (PD-1) and T cell Ig- and mucin-domain molecule 3 (Tim-3), which are potent co-inhibitory receptors, and their persistent expression often leads to T cell dysfunction and compromised protective immunity. We found that patients with the highest expression of PD-1 +Tim-3+ T cells in the memory compartment before transplantation had increased incidence of infections after liver transplantation, especially within the first 90 days. Longitudinal analysis in the first year showed a strong association between variability of PD-1 and Tim-3 expression by T cells and infectious episodes in transplant patients. Furthermore, T cells that expressed PD-1 and Tim-3 had a significantly reduced capacity in producing interferon (IFN)-γ in vitro, and this reduced IFN-γ production could be partially reversed by blocking PD-1 and Tim-3. Interestingly, the percentage of Foxp3+ regulatory T cells in liver transplant patients was stable in the study period. We concluded that the functional status of T cells before and after liver transplantation, as shown by PD-1 and Tim-3 expression, may be valuable in prognosis and management of posttransplant infections.

publication date

  • November 20, 2017

Research

keywords

  • Hepatitis A Virus Cellular Receptor 2
  • Immunologic Memory
  • Infections
  • Liver Transplantation
  • Postoperative Complications
  • Programmed Cell Death 1 Receptor

Identity

PubMed Central ID

  • PMC5790618

Scopus Document Identifier

  • 85034626432

Digital Object Identifier (DOI)

  • 10.1111/ajt.14546

PubMed ID

  • 29068155

Additional Document Info

volume

  • 18

issue

  • 2